Zheng Jian Li, PhD is an Executive Director at Bristol Myers Squibb (BMS) where he is leading the Biologics Analytical Development and Attribute Sciences. Before this role, he was the Executive Director at BMS leading the Late Stage Biologics Development. He has extensive experience in manufacturing process development for biological
molecules including various modalities and expression systems. His teams have extensive publications in various well known journals, which covers all aspects of issues related to biologics commercialization. Dr. Li received his Ph.D. in Chemical and Biochemical Engineering from University of Maryland Baltimore County in 2000.
Read More